Myriam Curet serves as Executive at NEKTAR THERAPEUTICS, where they oversee executive responsibilities. Since joining the company, Myriam Curet has executed 113 insider transactions totaling $35.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 25, 2022 involved selling 3,000 shares valued at $791.8K.
Myriam Curet currently holds 125 shares of NEKTAR THERAPEUTICS (NKTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Myriam Curet has been a net seller of NKTR stock. They have purchased $804 and sold $35.6M worth of shares.
Myriam Curet's most recent insider trade was on Jan 25, 2022, when they sold 3,000 shares at $263.94 per share.
Get notified when new Form 4 filings are submitted
| $109.49 |
| Discretionary |
| Jan 25, 2022 | ISRG | $791.8K | Sale | 3,000 | $263.94 | Discretionary |
| Jan 25, 2022 | ISRG | $418.6K | Option Exercise | 3,000 | $139.52 | Discretionary |
| Jan 4, 2022 | STXS | $0 | Award | 9,335 | $N/A | Discretionary |
| Oct 22, 2021 | ISRG | $2.0M | Sale | 6,000 | $339.64 | Discretionary |
| Oct 22, 2021 | ISRG | $656.9K | Option Exercise | 6,000 | $109.49 | Discretionary |
| Sep 22, 2021 | NKTR | $65.2K | Sale | 3,665 | $17.78 | Discretionary |
| Sep 22, 2021 | NKTR | $0 | Award | 10,200 | $N/A | Discretionary |
| Sep 9, 2021 | ISRG | $1.4M | Sale | 1,250 | $1082.54 | Discretionary |
| Sep 9, 2021 | ISRG | $3.2M | Sale | 3,000 | $1082.54 | Discretionary |
| Sep 9, 2021 | ISRG | $298.6K | Option Exercise | 1,250 | $238.91 | Discretionary |
| Sep 9, 2021 | ISRG | $985.4K | Option Exercise | 3,000 | $328.46 | Discretionary |